Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2016	Jun. 30, 2016
Current assets:
Cash	$ 20,098	$ 23,014
Accounts receivable - trade	170	484
Accounts receivable - unbilled	62	122
Work in process	0	22
Prepaid expenses and other current assets	132	264
Total Current Assets	20,462	23,906
Fixed assets, net of accumulated depreciation	25,580	25,574
Intangible assets, net of accumulated amortization	2,023	2,092
Security deposit	26	28
Total Assets	48,091	51,600
Current liabilities:
Accounts payable (related party of $239 and $200 as of September 30, 2016 and June 30, 2016, respectively)	979	1,177
Accrued expenses (related party of $772 and $623 as of September 30, 2016 and June 30, 2016 respectively)	1,022	920
Capital lease obligation - current portion	173	170
Deferred revenue	0	24
Total Current Liabilities	2,174	2,291
Capital lease obligation - net of current portion	25,220	25,265
Total Liabilities	27,394	27,556
Commitments and Contingencies
iBio, Inc. Stockholders’ Equity:
Preferred stock - no par value; 1,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock - $0.001 par value; 175,000,000 shares authorized; 89,109,410 shares issued and outstanding as of September 30, 2016 and June 30, 2016	89	89
Additional paid-in capital	67,733	67,468
Accumulated other comprehensive loss	(29)	(29)
Accumulated deficit	(60,652)	(57,591)
Total iBio, Inc. Stockholders’ Equity	7,141	9,937
Noncontrolling interest	13,556	14,107
Total Equity	20,697	24,044
Total Liabilities and Equity	$ 48,091	$ 51,600